Alembic Pharmaceuticals has informed that a meeting of the Board of Directors of the Company shall be held on April 28, 2014, to consider and approve the Audited Financial Results of the Company for the Financial Year ended March 31, 2014. Further, the trading window shall remain closed from April 25, 2014 to April 29, 2014 for the above purpose.
The above information is a part of company’s filings submitted to BSE.